>The chemoselective, continuous, multistep reduction of iodo‐nitroaromatics in a fixed‐bed hydrogenation reactor has been investig'/>
机译:连续铂介导的 Refametinib i> Refametinib Iodo-nitaniline键中间体dim-na:选择性和催化剂停用的组合挑战
PharmaceuticalsBayer AG42096 Wuppertal Germany;
PharmaceuticalsBayer AG42096 Wuppertal Germany;
Engineering &
TechnologyBayer AG51368 Leverkusen Germany;
Engineering &
TechnologyBayer AG51368 Leverkusen Germany;
Engineering &
TechnologyBayer AG51368 Leverkusen Germany;
Engineering &
TechnologyBayer AG51368 Leverkusen Germany;
PharmaceuticalsBayer AG42096 Wuppertal Germany;
Continuous flow; Flow chemistry; Hydrogenation; Heterogeneous catalysis; Nitroarenes; Online monitoring; UV/Vis spectroscopy;
机译:连续铂介导的 Refametinib i> Refametinib Iodo-nitaniline键中间体dim-na:选择性和催化剂停用的组合挑战
机译:PB 9 sub> 9(po 4 sub> 4) 6 sub> 6 / ag 3 sub> 3 po 4 sub> 4复合光催化剂,具有增强的可见光光催化活动
机译:AGCL / AG 3 sub> 3